Softgel Capsules Market Size, Share, Analysis, Trends, Growth, Forecast 2032

Softgel Capsules Market

Softgel Capsules Market Analysis By Product (Gelatin Softgel Capsule and Non-gelatin Softgel Capsule), By End-User (Pharmaceutical Companies and Contract Manufacturing Organizations), By Application (Anti-inflammatory Drugs, Antibiotic drugs, Health Supplements, and Cardiovascular Drugs), And By Region- Global Industry Perspective, Comprehensive Analysis, and Forecast, 2024 - 2032

Category: Healthcare Report Format : PDF Pages: 186 Report Code: ZMR-6766 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2.67 Billion USD 4.24 Billion 5.3% 2023

Table Of Content

  • Chapter 1. Preface
    • 1.1. Report Description and Scope
    • 1.2. Research Scope
    • 1.3. Research Methodulogy
      • 1.3.1. Market Research Type
      • 1.3.2. Market Research Methodulogy
  • Chapter 2. Executive Summary
    • 2.1. Softgel Capsules Market, 2018–2028(USD Billion)
    • 2.2. Softgel Capsules Market: Snapshot
  • Chapter 3. Global Softgel Capsules Market– Industry Analysis
    • 3.1. Softgel Capsules Market: Market Dynamics
    • 3.2. Market Drivers
      • 3.2.1. Drug suspension with unpleasant odor can be ingested easily in the softgel capsule as the product offers convenient consumption, thereby multiplying growth of softgel capsules industry.
      • 3.2.2. Increase in consumer inclination towards the product due to its self-lubricating chafracteristic as well as its availability in various sizes, chewable & meltable forms, and myriad culors will supplement expansion of softgel capsules market.
    • 3.3. Porter’s Five Forces Analysis
    • 3.4. Market Attractiveness Analysis
      • 3.4.1. Market attractiveness analysis By Product
      • 3.4.2. Market attractiveness analysis By End-User
      • 3.4.3. Market attractiveness analysis By Application
  • Chapter 4. Global Softgel Capsules Market– Competitive Landscape
    • 4.1. Company market share analysis
      • 4.1.1. Global Softgel Capsules Market: company market share, 2019
    • 4.2. Strategic development
      • 4.2.1. Acquisitions & mergers
      • 4.2.2. New Product launches
      • 4.2.3. Agreements, partnerships, cullaborations, and joint ventures
      • 4.2.4. Research and development and Regional expansion
    • 4.3. Price trend analysis
  • Chapter 5. Global Softgel Capsules Market– Product Analysis
    • 5.1. Global Softgel Capsules Marketoverview: By Product
      • 5.1.1. Global Softgel Capsules Marketshare, By Product, 2020 and 2028
    • 5.2. Non-gelatin Softgel Capsule
      • 5.2.1. Global Softgel Capsules Marketby Non-gelatin Softgel Capsule, 2018–2028(USD Billion)
    • 5.3. Gelatin Softgel Capsule
      • 5.3.1. Global Softgel Capsules Marketby Gelatin Softgel Capsule, 2018–2028(USD Billion)
  • Chapter 6. Global Softgel Capsules Marketoverview: By End-User
    • 6.1.1. Global Softgel Capsules Marketshare, By End-User, 2020 and 2028
    • 6.2. Pharmaceutical Companies
      • 6.2.1. Global Softgel Capsules Marketby Pharmaceutical Companies , 2018–2028(USD Billion)
    • 6.3. Contract Manufacturing Organizations
      • 6.3.1. Global Softgel Capsules Marketby Contract Manufacturing Organizations, 2018–2028(USD Billion)
  • Chapter 7. Global Softgel Capsules Marketoverview: By Application
    • 7.1.1. Global Softgel Capsules Market share, By Application, 2020 and 2028
    • 7.2. Anti-inflammatory Drugs
      • 7.2.1. Global Softgel Capsules Marketby Anti-inflammatory Drugs, 2018–2028(USD Billion)
    • 7.3. Antibiotic drugs
      • 7.3.1. Global Softgel Capsules Marketby Antibiotic drugs, 2018–2028(USD Billion)
    • 7.4. Cardiovascular Drugs
      • 7.4.1. Global Softgel Capsules Marketby Cardiovascular Drugs, 2018–2028(USD Billion)
    • 7.5. Health Supplements
      • 7.5.1. Global Softgel Capsules Marketby Health Supplements, 2018–2028(USD Billion)
  • Chapter 8. Company Profiles
    • 8.1. Catalent, Inc.
      • 8.1.1. Overview
      • 8.1.2. Financials
      • 8.1.3. Product Portfulio
      • 8.1.4. Business Strategy
      • 8.1.5. Recent Developments
    • 8.2. Capsugel
      • 8.2.1. Overview
      • 8.2.2. Financials
      • 8.2.3. Product Portfulio
      • 8.2.4. Business Strategy
      • 8.2.5. Recent Developments
    • 8.3. Elnova Pharma
      • 8.3.1. Overview
      • 8.3.2. Financials
      • 8.3.3. Product Portfulio
      • 8.3.4. Business Strategy
      • 8.3.5. Recent Development
    • 8.4. Hunan ER-KANG Pharmaceutical Co Ltd.
      • 8.4.1. Overview
      • 8.4.2. Financials
      • 8.4.3. Product Portfulio
      • 8.4.4. Business Strategy
      • 8.4.5. Recent Development
    • 8.5. Aenova Group GmbH
      • 8.5.1. Overview
      • 8.5.2. Financials
      • 8.5.3. Product Portfulio
      • 8.5.4. Business Strategy
      • 8.5.5. Recent Development
    • 8.6. Guangdong Yichao Biulogical Co., Ltd.
      • 8.6.1. Overview
      • 8.6.2. Financials
      • 8.6.3. Product Portfulio
      • 8.6.4. Business Strategy
      • 8.6.5. Recent Development
    • 8.7. Sirio Pharma Company Ltd
      • 8.7.1. Overview
      • 8.7.2. Financials
      • 8.7.3. Product Portfulio
      • 8.7.4. Business Strategy
      • 8.7.5. Recent Development
    • 8.8. Captek Softgel International Inc.
      • 8.8.1. Overview
      • 8.8.2. Financials
      • 8.8.3. Product Portfulio
      • 8.8.4. Business Strategy
      • 8.8.5. Recent Development
    • 8.9. Fuji Capsule Co., Ltd.
      • 8.9.1. Overview
      • 8.9.2. Financials
      • 8.9.3. Product Portfulio
      • 8.9.4. Business Strategy
      • 8.9.5. Recent Development
    • 8.10. EuroCaps Ltd.
      • 8.10.1. Overview
      • 8.10.2. Financials
      • 8.10.3. Product Portfulio
      • 8.10.4. Business Strategy
      • 8.10.5. Recent Development
    • 8.11. KD Pharma Group
      • 8.11.1. Overview
      • 8.11.2. Financials
      • 8.11.3. Product Portfulio
      • 8.11.4. Business Strategy
      • 8.11.5. Recent Development

Table Of Figures

List of Figures

1. Market research Type
2. Market research methodology
3. Global Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
4. Porter’s Five Forces Analysis
5. Global Clinical Trial Supply and Logistics Marketattractiveness, By Product
6. Global Clinical Trial Supply and Logistics Marketattractiveness, By End-User
7. Global Clinical Trial Supply and Logistics Marketattractiveness by Application 
8. Global Clinical Trial Supply and Logistics Marketshare by Product ,2020 and 2028 (USD Billion)
9. Global Clinical Trial Supply and Logistics Marketby Non-gelatin Softgel Capsule, 2018–2028(USD Billion)
10. Global Clinical Trial Supply and Logistics Marketby Gelatin Softgel Capsule, 2018–2028(USD Billion)
11. Global Clinical Trial Supply and Logistics Marketshare by End-User ,2020 and 2028 (USD Billion)
12. Global Clinical Trial Supply and Logistics Marketby Pharmaceutical Companies,  2018–2028(USD Billion)
13. Global Clinical Trial Supply and Logistics Marketby Contract Manufacturing Organizations, 2018–2028(USD Billion)
14. Global Clinical Trial Supply and Logistics Marketshare by Application ,2020 and 2028 (USD Billion)
15. Global Clinical Trial Supply and Logistics Marketby Anti-inflammatory Drugs, 2018–2028(USD Billion)
16. Global Clinical Trial Supply and Logistics Marketby Antibiotic drugs, 2018–2028(USD Billion)
17. Global Clinical Trial Supply and Logistics Marketby Health Supplements, 2018–2028(USD Billion)
18. Global Clinical Trial Supply and Logistics Marketby Cardiovascular Drugs, 2018–2028(USD Billion)
19. Global Clinical Trial Supply and Logistics Marketshare, by Region, 2020 and 2028
20. North America Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
21. Europe Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
22. Asia Pacific Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
23. Latin America Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
24. The Middle East and Africa Clinical Trial Supply and Logistics Market, 2018–2028(USD Billion)
 


Table Of Tables

List of Tables

1. Global Clinical Trial Supply and Logistics Market: snapshot
2. Drivers of the Clinical Trial Supply and Logistics Market: impact analysis
3. North America Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
4. North America Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
5. North America Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
6. The U.S. Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
7. The U.S. Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
8. The U.S. Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
9. Rest of North America Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
10. Rest of North America Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
11.  Rest of North America Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
12. Europe Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
13. Europe Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
14. Europe Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
15. UK Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
16. UK Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
17. UK Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
18. France Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
19. France Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
20. France Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
21. Germany Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
22. Germany Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
23. Germany Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
24. Rest of Europe Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
25. Rest of Europe Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
26. Rest of Europe Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
27. Asia Pacific Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
28. Asia Pacific Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
29. Asia Pacific Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
30. China Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
31. China Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
32. China Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
33. Japan Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
34. Japan Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
35. Japan Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
36. India Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
37. India Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
38. India Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
39. Rest of Asia Pacific Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
40. Rest of Asia Pacific Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
41. Rest of North America Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
42. Latin America Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
43. Latin America Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
44. Latin America Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
45. Brazil Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
46. Brazil Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
47. Brazil Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
48. Rest of Latin America Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
49. Rest of Latin  America Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
50. Rest of Latin America Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
51. The Middle East and Africa Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
52. The Middle East and Africa Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
53. The Middle East and Africa Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
54. Saudi Arabia Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
55. Saudi Arabia Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
56. Saudi Arabia Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
57. South Africa Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
58. South Africa Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
59. South Africa Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)
60. Rest of the Middle East & Africa Softgel Capsules Marketrevenue, By Product  ,2018–2028(USD Billion)
61. Rest of the Middle East & Africa Softgel Capsules Marketrevenue, By End-User ,2018–2028(USD Billion)
62. Rest of the Middle East & Africa Softgel Capsules Marketrevenue, By Application ,2018–2028(USD Billion)


 

Methodology

FrequentlyAsked Questions

Softgel capsules are gelatin-based capsules for medicines. They improve drug absorption and ease of swallowing
The global Softgel Capsules market is expected to be driven by the pharmaceutical and nutraceutical demand. Improved bioavailability and patient compliance boost adoption.
According to study, the global Softgel Capsules market size was worth around USD 2.67 Billion in 2023 and is predicted to grow to around USD 4.24 Billion By 2032.
The global Softgel Capsules market is expected to grow at a Compound Annual Growth Rate (CAGR) of around CAGR 5.3% during the forecast period from 2024-2032.
The global Softgel Capsules industry is projected to be challenged by Challenges include formulation stability and gelatin sourcing issues.
The Opportunities include dietary supplement growth, pharmaceutical delivery efficiency, consumer preference for easy dosing, and nutraceutical demand will offer significant growth opportunities in the Softgel Capsules market.
Improved bioavailability formulations; plant-based capsule shells; growth in nutraceutical and pharma use are the emerging trends and innovations impacting the Softgel Capsules market.
The global Softgel Capsules market is expected to be led by APAC during the forecast period.
Some of the prominent players operating in the global Softgel Capsules market are; Catalent, Inc., Capsugel, Elnova Pharma, Hunan ER-KANG Pharmaceutical Co Ltd., Aenova Group GmbH, Guangdong Yichao Biological Co., Ltd., Sirio Pharma Company Ltd, Captek Softgel International Inc, Fuji Capsule Co., Ltd., EuroCaps Ltd., and KD Pharma Group and others.
The report explores crucial aspects of the Softgel Capsules market, including a detailed discussion of existing growth factors and restraints, while also browsing future growth opportunities and challenges that impact the market.
  • zion payment modes

List of Contents

Market InsightsGlobal Industry Perspective:OverviewGrowth TrendsReport ScopeRegional LandscapeCompetitive LandscapeThe global Market is segmented as follows:

HappyClients